Observational studyCNS drugs2021

Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.

Nabil Seery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.